Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT03620981 · COMPLETED
Trial details
- NCT number
- NCT03620981
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-20
- Primary completion
- 2023-04-21
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.